28.08.2014 Views

Thailand - Stop TB Partnership

Thailand - Stop TB Partnership

Thailand - Stop TB Partnership

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Distribution<br />

In addition to manufacturing drugs, the GPO also oversees drug distribution. The Regional<br />

Office of Disease Prevention and Control directly distributes <strong>TB</strong> drugs to 19 zonal <strong>TB</strong> control<br />

centers, which in turn supply the provincial and district hospitals. District health workers<br />

then collect <strong>TB</strong> drugs from district hospitals, and supervise distribution by local health<br />

workers to patients.<br />

A case study in southern <strong>Thailand</strong> revealed drug shortages and overstocking at<br />

the local level, beyond the provincial and district hospitals’ control. According to the study,<br />

rifampicin was overstocked most frequently (five times the recommended amount) and<br />

shortages of ethambutol were most common. 137 Local solutions to these problems include<br />

extra purchasing, requesting additional drug supplies to cover shortages, and sending surplus<br />

drugs to other institutes. In 1999, approximately 555,000 baht ($14,681) worth of <strong>TB</strong><br />

drugs expired due to overstocking. 138 A more centralized system of drug management and<br />

distribution would help eliminate or decrease such inefficiencies.<br />

Education and research<br />

The MoPH has supported a range of operational research projects on issues related to <strong>TB</strong><br />

control. Thai <strong>TB</strong> experts emphasize the importance of prioritizing research that can be<br />

translated into policy, and of relating research priorities to the most pressing issues in the<br />

field, such as <strong>TB</strong>/HIV, the impact of health reforms on <strong>TB</strong> control, and the existence of<br />

subepidemics and inadequate access to services among vulnerable groups.<br />

To date, the NTP has prioritized operational research on DOTS, with a focus on<br />

evaluating DOTS implementation, the behavioral factors associated with adherence to <strong>TB</strong><br />

treatment, and the cost effectiveness of the <strong>TB</strong> control strategy. In addition, funding agencies<br />

such as the <strong>Thailand</strong> Research Fund and the Health System Research Institute have<br />

hosted meetings to brainstorm on <strong>TB</strong> research priorities. Regional and district-level research<br />

has reflected regional priorities such as <strong>TB</strong>/HIV (in the northern region) and the impact of<br />

decentralization on <strong>TB</strong> control activities (in Yala province, southern <strong>Thailand</strong>).<br />

The government should commit financial resources to conduct research on the<br />

following:<br />

• further standardization of <strong>TB</strong> diagnostic and treatment services to minimize the<br />

risk of MDR-<strong>TB</strong><br />

• the effects of sociocultural factors on <strong>TB</strong> adherence<br />

• techniques for diagnosing <strong>TB</strong> among HIV patients<br />

• the effect of health system reform on NTP implementation<br />

60<br />

<strong>TB</strong> POLICY IN THAILAND

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!